Trial Profile
An Open Label Parallel Group Study To Investigate The Pharmacokinetics Of Intravenous Linezolid, An Oxazolidinone, Administered To Healthy Volunteers And Patients With Major Thermal Injuries.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2009
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 25 Jul 2009 New trial record